Chemomab Therapeutics Ltd (CMMB)
0.68
-0.01
(-1.29%)
USD |
NASDAQ |
Apr 19, 12:03
Chemomab Therapeutics Max Drawdown (5Y): 99.73% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 99.73% |
| February 29, 2024 | 99.73% |
| January 31, 2024 | 99.73% |
| December 31, 2023 | 99.73% |
| November 30, 2023 | 99.71% |
| October 31, 2023 | 99.58% |
| September 30, 2023 | 99.48% |
| August 31, 2023 | 99.42% |
| July 31, 2023 | 99.42% |
| June 30, 2023 | 99.42% |
| May 31, 2023 | 99.18% |
| April 30, 2023 | 99.18% |
| March 31, 2023 | 99.17% |
| February 28, 2023 | 99.10% |
| January 31, 2023 | 98.90% |
| December 31, 2022 | 98.90% |
| November 30, 2022 | 98.87% |
| October 31, 2022 | 98.87% |
| September 30, 2022 | 98.65% |
| August 31, 2022 | 98.51% |
| July 31, 2022 | 98.51% |
| June 30, 2022 | 98.51% |
| May 31, 2022 | 98.51% |
| April 30, 2022 | 98.20% |
| March 31, 2022 | 97.96% |
| Date | Value |
|---|---|
| February 28, 2022 | 97.96% |
| January 31, 2022 | 97.33% |
| December 31, 2021 | 96.29% |
| November 30, 2021 | 95.09% |
| October 31, 2021 | 94.75% |
| September 30, 2021 | 94.44% |
| August 31, 2021 | 94.44% |
| July 31, 2021 | 94.44% |
| June 30, 2021 | 94.44% |
| May 31, 2021 | 94.44% |
| April 30, 2021 | 94.44% |
| March 31, 2021 | 94.44% |
| February 28, 2021 | 94.44% |
| January 31, 2021 | 94.44% |
| December 31, 2020 | 94.44% |
| November 30, 2020 | 94.44% |
| October 31, 2020 | 94.44% |
| September 30, 2020 | 94.44% |
| August 31, 2020 | 94.44% |
| July 31, 2020 | 94.44% |
| June 30, 2020 | 94.44% |
| May 31, 2020 | 94.44% |
| April 30, 2020 | 94.44% |
| March 31, 2020 | 94.44% |
| February 29, 2020 | 91.68% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
46.48%
Minimum
Apr 2019
99.73%
Maximum
Dec 2023
93.15%
Average
94.60%
Median
Max Drawdown (5Y) Benchmarks
| Compugen Ltd | 97.28% |
| Pluri Inc | 96.47% |
| BioLine Rx Ltd | 97.41% |
| Can Fite Biofarma Ltd | 99.32% |
| BiomX Inc | 98.75% |